BACKGROUND. Postnatal corticosteroids were widely used in the 1990s in an attempt to
reduce the incidence of bronchopulmonary dysplasia. However, high rates of short-term …

Importance The safety of postnatal corticosteroids used for prevention of bronchopulmonary
dysplasia (BPD) in preterm neonates is a controversial matter, and a risk-benefit balance …

Bronchopulmonary dysplasia (BPD) remains a major morbidity for infants born preterm.
Postnatal corticosteroids might reduce the risk of developing BPD, or reduce its severity …

Background Systematic reviews showed that systemic postnatal corticosteroids reduce the
risk of bronchopulmonary dysplasia (BPD) in preterm infants. However, corticosteroids have …

OBJECTIVE: To assess the safety and efficacy of IC for prevention or treatment of BPD or
death in preterm infants. DATA SOURCES: PubMed, the Cochrane Library, Embase, and …

Newborn infants born very preterm are at high risk of developing bronchopulmonary
dysplasia, which is associated with not only mortality but also adverse long-term …

Survival of extremely preterm infants has increased over recent years, but
bronchopulmonary dysplasia (BPD) remains a major cause of morbidity. In the USA, BPD is …

Postnatal corticosteroids are effective in preventing or treating bronchopulmonary dysplasia
(BPD) in preterm newborns, but their benefits need to exceed their risks. Several types of …

OBJECTIVE. Postnatal steroid use decreases lung inflammation but increases impairment.
We hypothesized that increased dose is associated with increased neurodevelopmental …

Aim: To survey practices in 14 European countries and describe strategies for the prevention
and treatment of bronchopulmonary dysplasia with postnatal steroids (PNS). Methods: In …